53873-024 : Dabrafenib Mesylate


NDC: 53873-024
Labeler: Glaxosmithkline Inc
Drug Name:  Tafinlar
Rev. Date: 


Appearance:


Markings: GSLHF;75mg
Shapes:  Oval
Colors:  Red
Size (mm): 20
Segments: * 1

* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines.

Active Ingredients:

  • Dabrafenib Mesylate

Inactive Ingredients:

  • Silicon Dioxide
  • Magnesium Stearate
  • Microcrystalline Cellulose
  • Hypromellose, Unspecified
  • Ferric Oxide Red
  • Titanium Dioxide /

Related Products:

Based on records with the same trade name.
  • 53873-023 Dabrafenib Mesylate by Glaxosmithkline Inc
  • 0078-0681 Tafinlar 75 mg Oral Capsule by Novartis Pharmaceuticals Corporation
  • 0078-0682 Tafinlar 50 mg Oral Capsule by Novartis Pharmaceuticals Corporation
  • 0078-1154 Tafinlar 10 mg Oral Tablet, for Suspension by Novartis Pharmaceuticals Corporation
  • 0173-0846 Tafinlar 50 mg Oral Capsule by Glaxosmithkline LLC
  • 0173-0847 Tafinlar 75 mg Oral Capsule by Glaxosmithkline LLC

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 53873-024 QR Code

< Prev: 53873-023Next: 53873-028 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.